Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04629209
Title A Phase II, Open Label Study of ONC201 in Adults With EGFR-low Glioblastoma
Recruitment Withdrawn
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Oncoceutics, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
University of Minnesota Minneapolis Minnesota 55455 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field